US Broker Ratings

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring the 89% Potential Upside with Promising Vaccine Innovations

Investors seeking opportunities within the biotechnology space may want to turn their attention to Vaxcyte, Inc. (NASDAQ: PCVX), a clinical-stage company making strides in vaccine innovation...

Bausch + Lomb Corporation (BLCO) Stock Analysis: Navigating Healthcare with 8.21% Upside Potential

Bausch + Lomb Corporation (NYSE: BLCO), a Canada-based leader in the healthcare sector, particularly within the medical instruments and supplies industry, is capturing the attention of..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a Potential 48.99% Upside

ADMA Biologics Inc (NASDAQ: ADMA), a key player in the healthcare sector, specializes in developing, manufacturing, and marketing plasma-derived biologics designed to treat immune deficiencies and..

Cytokinetics, Incorporated (CYTK): Investor Outlook Reveals 70% Upside Potential Amidst Biotech Challenges

Cytokinetics, Incorporated (NASDAQ: CYTK) stands at the crossroads of innovation and opportunity within the dynamic biotechnology sector. This biopharmaceutical company, headquartered in South San Francisco, is..

Krystal Biotech, Inc. (KRYS) Investor Outlook: Analyzing a Potential 19% Upside in the Biotech Sector

Krystal Biotech, Inc. (NASDAQ: KRYS), a promising player within the biotechnology industry, continues to capture investor attention with its innovative approach to genetic medicine. With a..

Bio-Techne Corp (TECH) Stock Analysis: Navigating a Market Valuation Amidst a Mixed Analyst Consensus

Bio-Techne Corp (NASDAQ: TECH), a key player in the biotechnology industry, presents a complex picture for investors seeking exposure to the healthcare sector. With a market..

Repligen Corporation (RGEN) Stock Analysis: A Healthcare Innovator with a 14.97% Potential Upside

Repligen Corporation (NASDAQ: RGEN), a leader in the healthcare sector specializing in medical instruments and supplies, continues to capture the attention of investors with its robust..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: A Biotech Innovator with a 166% Potential Upside

Atrium Therapeutics, Inc. (RNA) stands out in the biotechnology sector with its pioneering focus on RNA-based therapies for cardiomyopathies. As a company at the forefront of..

Stevanato Group S.p.A. (STVN) Stock Analysis: Understanding the 28.18% Potential Upside

Investors eyeing opportunities in the healthcare sector may find Stevanato Group S.p.A. (NYSE: STVN) a compelling case for further analysis. With a market capitalization of $5.29..

Globus Medical, Inc. (GMED) Stock Analysis: A 29% Potential Upside Amidst Strong Buy Ratings

Investors eyeing the healthcare sector should pay close attention to Globus Medical, Inc. (NYSE: GMED), a leading player in the medical devices industry. With a market..

Oscar Health, Inc. (OSCR) Stock Analysis: A Look at Its 19.86% Potential Upside

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare technology sector, has been turning heads with its innovative approach to healthcare plans. With a..

Integer Holdings Corporation (ITGR) Stock Analysis: What Investors Need to Know About the Healthcare Giant

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the medical device sector, presents a unique investment opportunity within the healthcare industry. Headquartered in Plano, Texas,..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating the Healthcare Market with a Promising Technology

Inspire Medical Systems, Inc. (NASDAQ: INSP) has carved a niche within the healthcare sector, focusing on innovative solutions for obstructive sleep apnea (OSA), a condition affecting..

Alkermes plc (ALKS) Stock Analysis: Exploring a 24% Upside Potential with Strong Buy Ratings

Alkermes plc (NASDAQ: ALKS), a biopharmaceutical company based in Dublin, Ireland, is drawing significant attention from investors, thanks to its robust pipeline and promising growth metrics...

TG Therapeutics, Inc. (TGTX): Investor Outlook on a Booming Biotech with 13.95% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) is capturing the attention of the investment community with its promising outlook and robust performance metrics. As a commercial-stage biopharmaceutical company..

The Ensign Group, Inc. (ENSG) Stock Analysis: Uncovering a 23.18% Potential Upside in Healthcare Investment

The Ensign Group, Inc. (NASDAQ: ENSG) presents a compelling investment opportunity within the healthcare sector, particularly for those eyeing the medical care facilities industry. With a..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Biotechnology Innovator with 16.20% Upside Potential

Sarepta Therapeutics, Inc. (SRPT), a key player in the biotechnology sector, is drawing investor attention with its innovative approach to treating rare diseases and a notable..

Waystar Holding Corp. (WAY) Stock Analysis: Healthcare Innovator with 21.75% Potential Upside

Waystar Holding Corp. (NASDAQ: WAY), with its innovative cloud-based software solutions for healthcare payments, is capturing the attention of investors seeking growth in the healthcare sector...

Revolution Medicines, Inc. (RVMD): Investor Outlook Highlights 35% Potential Upside Amidst Robust Buy Ratings

Revolution Medicines, Inc. (NASDAQ: RVMD) is capturing investor attention with a promising 35.30% potential upside, as indicated by the average analyst target price of $258.84 compared..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating the Investment Landscape with a Potential 9.99% Downside

Bio-Rad Laboratories, Inc. (NYSE: BIO), a key player in the healthcare sector and specifically in the medical devices industry, presents a compelling case for investors looking..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds